LILRA2 (Gene)

Organism:

Homo sapiens

Synonyms:CD85H, ENTREZ:11027, HGNC:6603, ILT1, LILRA2, LIR-7, LIR7, MIM:604812, NM_001130917, NM_001290270, NM_001290271, NM_006866, NP_001124389, NP_001277199, NP_001277200, NP_006857, XM_006722986, XM_011526385, XM_011526386, XM_011526387, XM_011526388, XM_011526389, XM_011526390, XM_011526391, XM_017026224, XP_006723049, XP_011524687, XP_011524688, XP_011524689, XP_011524690, XP_011524691, XP_011524692, XP_011524693, XP_016881713, leukocyte immunoglobulin like receptor A2

Id:ENSG00000239998

Entrez:11027

Ensembl:ENSG00000239998

Description:leukocyte immunoglobulin like receptor A2

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View LILRA2's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with LILRA2.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using LILRA2.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for LILRA2.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with LILRA2.

Results found

Linked to

	Label	Description
	GSE171837 bortezomib 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182150 KIT LSD1 MYC inhibition 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE171837 0 V 1 BORTEZOMIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE171837 bortezomib 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE191005 ENL knockout MOLM-13 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE129698 SYK inhibition 3 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199204 GSE211619 glutamine 4 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE201309 matrine 1 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE171837 bortezomib 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE171837 bortezomib 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE182150 KIT LSD1 MYC inhibition 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE171837 0 V 1 BORTEZOMIB HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE171837 bortezomib 0 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE191005 ENL knockout MOLM-13 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE129698 SYK inhibition 3 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 2 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE199204 GSE211619 glutamine 4 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE201309 matrine 1 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE171837 bortezomib 3 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.